Loading…

Peptreon's shares fell 4.54% to 94,600 won in morning trading after the company announced Mexican regulatory approval for Luprone (PT105), a one-month sustained-release leuprolide injection. The approved product name in Mexico is LUPUNIA.
This is a pharmaceutical equity story with no bearing on feed grains, oilseeds, or animal-feed commodity supply, demand, or prices.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.